EPITHELIAL NA CHANNELS (ENaC) are sodium-permeable ion channels located in the apical membrane of polarized epithelial cells primarily in the distal nephron, lung, and distal colon. In the distal nephron, the activity of ENaC is the rate-limiting step for Na ϩ reabsorption (17, 57) ; therefore, ENaC activity is critical in the physiological maintenance of systemic Na ϩ homeostasis and long-term control of blood pressure. Because of its central role in responding to changes in Na ϩ uptake, ENaC activity is tightly regulated; abnormal regulation of this channel has been linked to several genetic disorders involving abnormal blood pressure including Liddle's syndrome and pseudohypoaldosteronism type 1. ENaC is regulated by many intracellular as well as extracellular factors, among these G protein-coupled receptors (GPCRs), which transduce a variety of extracellular signals to several different intracellular signaling pathways that have been implicated in ENaC regulation. Trimeric G proteins are a family of 40-to 50-kDa proteins that each consist of three subunits: one ␣, one ␤, and one ␥. Ligand binding to a GPCR leads to a series of events. First, GDP bound to the ␣ subunit is replaced with GTP, after which the ␣ subunit dissociates from the ␤␥ subunits. The ␤␥ subunits remain tightly associated with each other and remain anchored in the membrane via myristoylation of the ␥ subunit. Generally, the immediate GPCR signal is mediated by the intracellular association of the GTP-bound G ␣ with signaling molecules that are subsequently activated. ␣ Subunits fall into many different categories. The most common are stimulators of adenylyl cyclase, G ␣s , inhibitors of adenylyl cyclase, G ␣i , and activators of phospholipase C, G ␣q . Several GPCRs alter ENaC activity after interacting with their ligands. Vasopressin (8, 13) , ␤-adrenergic agents, dopamine, purines, adenosine, angiotensin II, endothelin, and many others all activate GPCRs, and the activated ␣-subunits modulate ENaC activity. Occasionally, G protein ␣ subunits interact directly with effector proteins including ENaC rather than first interacting with signaling intermediates (1, 16, 32, 50 -52, 69) .
All of these G protein effects are mediated by the release of the G protein ␣ subunits, but in every case a ␤␥ dimer is also released. In some circumstances, GPCR effects coupled to Gi/o signaling are mediated by G ␤␥ (18) ; however, there are few descriptions of the effects of ␤␥ dimers on ENaC regulation. G ␤␥ might inhibit ENaC activity through several downstream events. G ␤␥ can stimulate phospholipase C-␤ isoforms (PLC-␤) and promote phosphorylation of PLC-␥, which can, in turn, hydrolyze phosphatidylinositol 4,5-bisphosphate {[PI(4,5)P(2)]; PIP 2 } and generate the second messengers: inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DAG). PIP 2 is essential for ENaC gating (33, 44, 69) so that hydrolysis will reduce ENaC activity while the hydrolysis products, IP 3 and DAG, may further activate PKC and thereby inhibit ENaC open probability (P o ) and surface expression (6, 28) . G ␤␥ may also trans-activate receptor tyrosine kinases such as EGFR or TGFR (39, 56) , after which these receptors initiate signaling cascades that inhibit ENaC activity (19, 37, 61) .
In the human genome, there are 5 G ␤ and 12 G ␥ isoforms as well as two additional ␤ splice variants. The ␤ subunits all have high sequence identity: ␤1 through ␤4 have 78 -88% amino identity (24) , and ␤ 5 is ϳ50% identical to other ␤ subunits (64) . In contrast, all ␥ subunits are more diverse, ranging from 27 to 76% amino acid identity; therefore, the signaling specificity of G ␤␥ was assumed to be based on the ␥ subunits (12, 30, 49) . However, recent research shows that, in fact, ␤ subunits determine the effector specificity (26, 27, 47) . Most G ␤ and G ␥ subunits can form dimers in vitro, but in vivo studies have indicated that there are preferential associations for different G ␤␥ subunits in living cells, and these preferential associations may play an important role in determining the signaling specificity (46) .
To address the effect of G ␤␥ , particularly the specificity of ␤ isoforms, on ENaC regulation, we examined the effect of combinations of ␤1 through ␤5 with ␥ 2 on endogenous ENaC in A6 cells, a Xenopus laevis kidney cell line. The ␥ 2 subunit was chosen because dimers containing this isoform are active in most assays of ␤␥ function (49) . By using patch-clamp and single-channel recording, we show that only ␤ 1 ␥ 2 inhibits ENaC activity among these five combinations, and this inhibition is primarily mediated by ␤ 1 ␥ 2 activation of PLC and subsequent activation of PKC and ERK1/2.
METHODS
A6 cell culture and gene transfection. A6 cells were maintained in plastic tissue culture flasks at 26°C with 4% CO 2 in air; cells between passages 97 and 104 were grown on permeable filters for patch-clamp recording (66) . A6 cells were transfected with G ␥2 (in pIRES2-DsRed-Express bicistronic vector) combined with different G␤ (in pIRES2-EGFP bicistronic vector) with Lipofectamine 2000 transfection reagent (Invitrogen) at initial cell confluence.
Single-channel recordings. A6 cell single-channel recording was performed in cells expressing both green fluorescent protein (GFP) and red fluorescent protein (RFP) 4 -7 days posttransfection. All experiments were carried out with cell-attached configuration. The bath and pipette solutions were the same, containing (in mM) 96 NaCl, 3.4 KCl, 0.8 MgCl 2, and 10 HEPES; pH 7.4. In general, cells were not exposed to patch-clamp solution for more than 2 h. The pipette holding potential (ϪV pip) was 0 or Ϫ10 mV, and the recording duration was 8 -10 min.
Drug treatments. The ERK1/2 kinase inhibitor U0126, PLC inhibitor U73122, and its inactive analog U73433 were obtained (Sigma), and all were dissolved in DMSO at 10 mM for stock and used as 10 M; the PKC inhibitor GF109203X and Src family kinase inhibitor PP2 (Calbiochem) were prepared as 2 mM stocks in DMSO and finally used as 0.4 and 2 M, respectively; the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 (Cell Signaling) was dissolved in 10 mM DMSO and applied as 10 M. Drugs were added to the bath solution at least 20 min before channel recording.
Real-time PCR. We recovered five G␤ sequences, ␤1-␤5, from GenBank and developed multiple sets of potential primers for each subunit. We examined the melt curves for each primer and selected five pairs with the highest selectivity (given in Table 1 ). The lower detection limit with our PCR unit (Bio-Rad Icycler) was 40 cycles. All levels of expression were referenced to ␤2, which was not detected at Ͻ40 cycles. The efficiency of the PCR reaction was determined with a plasmid containing ␤1 as 1.96-fold/cycle, and fold-changes were calculated accordingly.
Data analysis. All data acquisition and analysis were performed as described previously (66) . Data are reported as means Ϯ SE. Statistical analysis was performed by SigmaPlot and SigmaStat software (Jandel Scientific). Differences between groups were evaluated with one-way ANOVA, and results were considered significant if P Ͻ 0.05.
RESULTS
Prior work has shown that ␤␥ subunits can, under appropriate conditions, alter ENaC activity (69), but which ␤ subunits are responsible for the effects was unclear.
G ␤ subunits in A6 cells. We used quantitative PCR to determine message levels for different G ␤ subunits. Primers were developed from GenBank sequences and tested for specificity using melt curve analysis. Relative amounts of message for different G ␤ subunits were calculated based on threshold cycle crossing. Figure 1 shows that the major subunit present on A6 cells is ␤1 with over 3.31 times more than ␤4, the next most common subunit. ␤1 is also over 75 times more prevalent than ␤5 and 465 greater than ␤3. ␤2 was not detectable (although the primers could easily amplify ␤2 present in plasmid DNA). We used Western blots to look for G ␤ protein. Table 1 ). The lower detection limit with our PCR unit (Bio-Rad Icycler) was 40 cycles. All levels of expression were referenced to ␤2, which was not detected at less than 40 cycles. Threshold cycles for each subunit are given in Table 1 . The efficiency of the PCR was determined with a plasmid containing ␤1 as 1.96-fold per cycle, and foldchanges shown in this figure were calculated accordingly. Standard deviations for all subunits are too small to be visible in this plot. Every value is significantly different from every other value (ANOVA with Holm-Sidak posttest, P Ͻ 0.05). B: Western blots of G␤ subunits in A6 cells. Whole lysate from 2F3 cells were probed with antibodies to G␤1, G␤2, and G␤4. Antibodies were obtained from Santa Cruz Biotechnology. These subunits were chosen since they represent quite different levels of expression: ␤1, high; ␤2, undetectable; ␤4, very low, but detectable. Twenty-five micrograms of total protein was loaded in each lane with antibodies at 1:500. All secondary antibodies were used at 1:5,000. G␤1 and G␤2 used anti-rabbit secondary antibody, and G␤4 used goat anti-mouse secondary antibody. G␤1, G␤2, and G␤4 are expected to run between 35 and 37 kDa as does G␤1. G␤2 and G␤4 are not detectable.
We chose ␤1, ␤2, and ␤4 as examples of a highly expressed, moderately expressed, and very poorly expressed subunit, respectively. Figure 1 shows that ␤1 is easily detected, but that the other two subunits are not detectable. This result suggested that the most likely G ␤ subunits to regulate ENaC in A6 cells would be ␤1, but ␤4, ␤3, or ␤5 might also be involved. (An examination by Western blotting of ␤ subunits in another cell line that expresses ENaC, mpkCCD-I4 cells, showed the same subunits as A6 cells in the same proportion except that ␤2 was at levels comparable to ␤4; data not shown). We did not examine the prevalence of ␥ subunits since there are a large number of them, but the ␥ 2 subunit was chosen because dimers containing this isoform are active in most assays of ␤␥ function and because it is common in most epithelia (49) .
Effect of different G ␤␥ combinations on ENaC activity. Transfection efficiency of A6 cells is low. To perform patchclamp recording on cells expressing both G ␤ and G ␥ subunits, G ␤ was inserted in the second cloning site of the bicistronic vector pIRES-GFP, which expresses GFP coordinately with the gene construct, while G ␥ was inserted into the bicistronic vector pIRES-DsRED, which expresses RFP coordinately. Single-channel, cell-attached patches were only formed on cells that expressed both GFP and RFP, the reporter genes for G ␤ and G ␥ , respectively. To eliminate variability in ENaC activity, which may arise among cells of different passages or even among cells on different days after gene transfection, control cells which only expressed reporter genes were always recorded in parallel with cells coexpressing G ␤␥ . The singlechannel conductance of ENaC, regardless of which G ␤␥ combination was expressed in cells, is ϳ4 pS, which is similar to that of ENaC in cells transfected with empty vectors; however, the five combinations do have different effects on ENaC activity (average channel activity; NP o ). In G ␤1␥2 -expressing cells, channel activity is significantly reduced, while other ␤␥ combinations produced no significant effect on ENaC activity. Typical single-channel traces recorded from control and G ␤1␥2 -expressing cells are shown in Fig. 2A ; the NP o , channel number within a patch (N) and channel (P o ) of these two groups of cells are presented in Fig. 2 , B-D. The NP o of G ␤1␥2 -expressing cells is 0.07 Ϯ 0.02 (n ϭ 25), which is significantly lower than the control value of 0.39 Ϯ 0.13 (n ϭ 29), P ϭ 0.003. To further analyze whether channel N and/or P o is reduced by G ␤1␥2 , we estimated channel density (N) by counting the maximum level of unitary current. If the recording period is sufficiently long (usually Ͼ10 min) (45) and if P o is between 0.1 and 0.9, N can be determined with Ͼ95% confidence. In our experiments, each patch was recorded for ϳ10 min, and therefore we should have reasonable estimates of channel N and also channel P o by dividing NP o by N. The channel density, N, is 1.12 Ϯ 0.03 (n ϭ 25) for G ␤1␥2 -expressing cells. This is significantly lower than control cells with an N of 2.34 Ϯ 0.54 (n ϭ 29) (P ϭ 0.05) (Fig. 2C ). In parallel with the decrease in N, P o of G ␤1␥2 -expressing cells is 0.05 Ϯ 0.01 (n ϭ 11), which is also significantly reduced compared with its control value of 0.12 Ϯ 0.02 (n ϭ 18), P ϭ 0.027 (Fig. 2D) .
In the same way, we also examined the effect of G ␤2 -G ␤5 combinations with G ␥2 on ENaC regulation. The average channel NP o of these G ␤␥ -expressing cells is presented side by side with the average values from their respective controls (Fig. 3, A-C) . NP o of G ␤2␥2 -expressing cells is 0.17 Ϯ 0.05 (n ϭ 33) and that of its control is 0.15 Ϯ 0.05 (n ϭ 36); NP o of G ␤3␥2 -and G ␤4␥2 -expressing cells is 0.12 Ϯ 0.05 (n ϭ 15) and 0.12 Ϯ 0.03 (n ϭ 31), and that of their control is 0.1 Ϯ 0.03 (n ϭ 33), respectively. Finally, NP o of G ␤5␥2 -expressing cells is 0.11 Ϯ 0.04 (n ϭ 32), while that of its control is 0.07 Ϯ 0.02 (n ϭ 30). In contrast to the significant inhibitory effect of G ␤1␥2 on ENaC activity, the rest of the four G ␤␥ combinations have no significant effect on ENaC activity. We also analyzed functional ENaC surface density (N) and channel gating (P o ) of these cells, and we found that both parameters in control and these four G ␤␥ -expressing cells are similar (data not shown). There is often substantial variability of P o for ENaC from different passages of cells and after different numbers of days in culture. In fact, single-channel activity of control cells recorded in parallel with any of these four G ␤␥ (␤2-␤5)-expressing cells is low (NP o of the control cells was Ͻ0.15). We speculated that the low P o might disguise the effect of these G ␤␥ subunits. Therefore, to further investigate the specificity of the G ␤␥ effects, we reexamined G ␤4␥2 and G ␤5␥2 in cells with higher ENaC channel activity. Early-passage cells that are just confluent tend to have a higher P o . We measured an ENaC NP o of G ␤4␥2 -or G ␤5␥2 -expressing cells of 0.57 Ϯ 0.12 (n ϭ 23) and 0.50 Ϯ 0.12 (n ϭ 24), respectively, which even with the high initial P o was again not significantly different from the NP o of 0.59 Ϯ 0.19 (n ϭ 32) measured in control GFP-and RFP-expressing cells. This result implies that the inhibitory effect of G ␤1␥2 on endogenous ENaC of A6 cells is isoform specific, and that the lack of effect of G ␤2␥2 -G ␤5␥2 combinations on ENaC in A6 cells is not because of low ENaC activity in particular passages of cells.
A PLC inhibitor blocks G ␤1␥2 inhibition of ENaC activity. In the context of mammalian cellular signaling, all four PLC-␤ isoforms are activated by the ␣ subunit of G q , but PLC-␤2 and -␤3 are also activated by G ␤␥ subunits (21) . To examine whether the inhibitory effect of G ␤1␥2 on ENaC is due to PLC activation in A6 cells (43) , we recorded ENaC activity in control and G ␤1␥2 -expressing cells after treating the cells with the PLC inhibitor U73122 or its inactive analog U73433 (both 10 M; IC 50 ϭ 5 M) (4) (Fig. 4) . In Fig. 4A , NP o of G ␤1␥2 -expressing cells treated with U73122 is 0.31 Ϯ 0.11 (n ϭ 27), while NP o of cells exposed to the inactive analog U73433 is 0.07 Ϯ 0.02 (n ϭ 33), which is significantly lower than the PLC inhibitor-treated cells (P ϭ 0.028). While N of U73433-treated cells is 1.29 Ϯ 0.26 (n ϭ 28), N of U73122-treated cells is 2.59 Ϯ 0.47, (n ϭ 27), which is significantly higher than N of cells treated with the inactive analog (P ϭ 0.017) (Fig. 4B) . U73122 also restored channel P o [P o of U73122-exposed cells is 0.09 Ϯ 0.02 (n ϭ 19), while P o of U73433-exposed cells is 0.05 Ϯ 0.01 (n ϭ 15), P ϭ 0.049, Fig.  4C ]. The effect of U73122 is on the G ␤1␥2 -induced PLC activity since there was no effect of the inhibitor on control, untransfected cells. In control cells, NP o , N, and P o of U73122- (Fig. 4, B and C) . That is, in contrast to the significant effect of U73122 on ENaC of G ␤1␥2 -expressing cells, the inhibitor has no significant effect on the channel activity in control, empty vector-expressing cells. These results imply that the activation of PLC contributes to G ␤1␥2 inhibition of ENaC.
A PKC inhibitor attenuates G ␤1␥2 suppression of ENaC activity. The above results show that a PLC inhibitor restored both channel N and P o of G ␤1␥2 -expressing cells. Several previous reports have shown that the primary effect of PI(4,5)P 2 does not change the density of functional ENaC on the apical surface but rather alters ENaC P o (33, 44, 53) ; therefore, the restoration of ENaC P o after inhibition of PLC is likely due to maintaining high levels of PIP 2 after prevention of PIP 2 hydrolysis. However, it is unclear whether typical PKC isoforms, which can be activated by PIP 2 hydrolytic products IP 3 and DAG (56), contribute to G ␤1␥2 -induced ENaC inhibition in A6 cells (6, 35, 55) . To examine this possibility, we treated G ␤1␥2 -expressing cells and control GFP-and RFPexpressing cells with the PKC inhibitor GF109203x [(IC 50 ) ϭ 360 nM (25) ] and compared the channel activity of these cells (Fig. 5) . GF109203x (0.4 M) has no effect on channel activity of control cells (NP o of treated vs. untreated cells is 0.56 Ϯ 0.2, n ϭ 22, vs. 0.55 Ϯ 0.17, n ϭ 17), but GF109203x significantly reduced the inhibitory effect of G ␤1␥2 on ENaC activity. In G ␤1␥2 -expressing cells, NP o in the absence of GF109203x-treated cells is 0.23 Ϯ 0.07 (n ϭ 29), which as expected, is significantly lower than that of control vector-expressing cells, P ϭ 0.05 (Fig. 5A, filled column) . When G ␤1␥2 -expressing cells were exposed to GF109203x, NP o increased to 0.50 Ϯ 0.1 (n ϭ 31), which approaches that of control, GFP-, and RFPexpressing cells (Fig. 5A, open column) . We further examined the effect of the PKC inhibitor on channel N and P o in G ␤1␥2 -expressing cells. GF109203x increased channel P o only slightly but significantly restored channel N of G ␤1␥2 -expressing cells (Fig. 5, B and C) ; N increased from 1.55 Ϯ 0.35, n ϭ 29, to 2.74 Ϯ 0.42, n ϭ 31, P ϭ 0.03. This result implies that PKC of A6 cells was activated by G ␤1␥2 overexpression, and this activation resulted in reducing the density of functional channels but has little effect on channel P o .
ERK1/2 is activated in G ␤1␥2 -expressing cells.
In certain cellular contexts, the transient expression of G ␤␥ heterodimers results in sustained activation of the ERK1/2 kinase cascade (15, 22) . The C-terminal tails of ␤-and ␥-ENaC contain ERK1/2 phosphorylation sites (59), and ERK1/2 was reported to participate in EGF-or TGF-␣ mediated inhibition of amiloride-sensitive transepithelial sodium current in A6 cells and in mouse cortical collecting duct cells (5, 37, 60, 62) . To address whether ERK1/2 kinase participates in G ␤1␥2 inhibition of ENaC in A6 cells, we examined the effects of the kinase inhibitor U0126 (1 M; IC 50 ϭ 0.07 M for MEK 1 and 0.06 M for MEK 2) (11) on ENaC activity of G ␤1␥2 -expressing cells. In Fig. 6A , when G ␤1␥2 -expressing cells were exposed to the vehicle, DMSO, alone, the average NP o is 0.3 Ϯ 0.07 (n ϭ 22); however, NP o is significantly increased to 0.75 Ϯ 0.15 (n ϭ 28) (P Ͻ 0.01) when these cells were treated with U0126. While U0126 has almost no effect on GFP-and RFP-coexpressing cells cultured in parallel, ENaC NP o of U0126-exposed cells is 0.76 Ϯ 0.17 (n ϭ 22) and for DMSO-exposed cells is 0.72 Ϯ 0.2 (n ϭ 16). Further analyzing channel N and P o of all these cells, we found that the average N and P o of GFP-and RFP-expressing cells were not affected by U0126, but U0126 significantly stimulated both N and P o of G ␤1␥2 -expressing cells. N of cells treated with U0126 vs. the untreated cells is 4 Ϯ 0.5 (n ϭ 28) vs. 2.3 Ϯ 0.07 (n ϭ 22), P Ͻ 0.01; P o of treated vs. untreated is 0.17 Ϯ 0.03 (n ϭ 21) vs. 0.11 Ϯ 0.02 (n ϭ 19), P Ͻ 0.01 (Fig. 6, C and D) . This result indicates that ERK1/2 kinase basal activity is low in unstimulated A6 cells but that it was activated by G ␤1␥2 expression and this activation inhibits both N and P o of ENaC.
Substantial literature indicates that G ␤␥ can induce ERK1/2 activation via PKC-dependent and PKC-independent pathways (20, 48, 56, 58) . In the PKC-independent pathway, G ␤␥ may activate ERK1/2 through PI3K activation (7), or by transactivating other classes of cell surface receptors, such as receptor tyrosine kinases, or integrins at focal adhesion complexes (40, 58) . In these PKC-independent mechanisms, Src family nonreceptor tyrosine kinases are usually involved as early intermediates which link G ␤␥ to activation of the Ras-MAPK pathway (39) . To test whether PKC-independent pathways were involved in G ␤1␥2 activation of ERK1/2, we studied the effect of PI3K and Src kinase inhibitors, respectively, on G ␤1␥2 -mediated ENaC inhibi- tion. We first recorded ENaC activity from control or G ␤1␥2 -expressing cells which have been treated with or without PI3K inhibitor LY294002 (10 M; IC 50 : 3.8 M) (63) . As the results presented in Fig. 7A show, ENaC NP o of G ␤1␥2 -expressing cells is significantly inhibited in the absence of LY294002 (the grey bars), and this inhibition was partially reversed when these cells were exposed to LY294002 (open bars). In contrast, LY294002 also tends to inhibit ENaC activity in cells expressing GFP and RFP alone, although this inhibition is not significant. The inhibitor of Src family kinases PP2 (10 M; IC 50 ϭ ϳ1 M) (38) affects neither ENaC in control cells nor ENaC in G ␤1␥2 -expressing cells (Fig. 8) . Therefore, the results of these two sets of experiment imply that neither PI3K nor Src kinases are significantly involved in transferring signaling from G ␤1␥2 to ERK1/2.
DISCUSSION
Many G protein-coupled receptors have been described in renal epithelial cells and specifically in A6 cells. These include type 2 vasopressin receptors (45), endothelin receptors (16), purinergic receptors (42, 43, 70) , prostaglandin receptors (31, 36), dopaminergic receptors (23) , and adenosine receptors (41) . Descriptions of the physiological effects of G protein activation on ENaC in A6 cells have a long history (1, 2, 9, 10, 50, 54). One initial report showed that the major G protein in the apical membrane of several epithelial cell lines was G i-3 (14) . Subsequent work showed that application of G ␣i-3 to the cytosolic surface of patches excised from the apical membrane activated amiloride-sensitive Na ϩ channels (9, 10, 69). The presumption was that somehow the G ␣ subunit was responsible for the activation; however, at that time the role of ␤␥ subunits was not appreciated. Only later was it shown that application of ␤␥ subunits strongly inhibited ENaC (69) . The model that emerged was one in which the primary role of the ␣ subunits was to sequester and, thereby, regulate the levels of ␤␥, with the ␤␥ subunits being the primary regulators of and interacting partners with ENaC. The ␤␥ subunits achieved this by regulating phospholipase C and PIP 2 levels and by direct interaction with PIP 2 and ENaC.
When we examined A6 cells by real-time PCR, the subunit with the highest level of expression was ␤1, but we could also detect ␤4 and low levels of ␤3 and ␤5. We were unable to amplify ␤2. The differences were even more dramatic in Western blots in which we could easily detect ␤1 but not ␤2 or ␤4. Therefore, it seemed that if a subunit were to modify activity in A6 cells it was likely to be ␤1. However, that ␤1 was the predominant subunit in A6 cells did not preclude the possibility that other ␤ subunits might also alter ENaC activity.
Using patch-clamp, single-channel recording, we examined different isoforms of G ␤ subunits in combination with ␥2 on endogenous ENaC regulation. Since ENaC activity can vary significantly among different passages or even among cells on different days after confluence, we used cells expressing GFP and RFP alone as a control for each drug treatment to ensure the significance of the results. In this study, we have recorded from Ͼ800 patches on A6 cells and found that ENaC activity is significantly inhibited only by the combination of G ␤1␥2 . The inhibitory effect of G ␤1␥2 is statistically significant in five of six independent experiments, while one did not reach a significant level of inhibition, but this is also the group of cells with the largest variation of ENaC activity among both control and G ␤1␥2 -expressing cells (presented in Fig. 7) .
In contrast to the significant effect of G ␤1␥2 , we found the other combinations of dimers from G ␤2␥2 to G ␤5␥2 have no significant effect on ENaC regulation. The lack of an inhibitory effect of G ␤2␥2 through G ␤4␥2 surprised us because ␤1 through ␤4 share Ͼ80% identity at an amino acid level (but Ͻ50% identity to ␤5). We repeated G ␤4␥2 and G ␤5␥2 combinations in certain passages of A6 cells which have higher endogenous ENaC activity and found again that these two combinations have no effect on ENaC activity. The specific effect of G ␤1␥2 on ENaC of A6 cells could be due to different G ␤ isoforms interacting with G ␥2 with different affinities (46) , or that G ␤1␥2 mediates cell type-specific signaling in A6 cells.
In exploring the mechanism of G ␤1␥2 inhibition of ENaC, we applied several kinase inhibitors to probe signaling pathways that transduce the signal from G ␤1␥2 to ENaC. The PLC inhibitor U73122 reversed the inhibitory effect of G ␤1␥2 on ENaC P o and N (Fig. 3, B and C) . In cells expressing GFP and RFP alone, U73122 tends to increase ENaC P o but the increase is not significant. Coincidentally, ENaC activity of G ␤1␥2 -expressing cells treated with inactive PLC inhibitor analog U73433 (Fig. 3A) is almost identical to that of G ␤1␥2 -expressing cells presented in Fig. 1B (both NP o ϭ 0.07 Ϯ 0.02), and therefore we can compare the results presented in these two figures. U73122 treatment brings the value for N of G ␤1␥2 -expressing cells close to that of GFP-and RFP-expressing cells (2.59 Ϯ 0.46 vs. 2.34 Ϯ 1.12) and brings P o of those cells to 80% of the control level (0.09 Ϯ 0.02 vs. 0.12 Ϯ 0.02). This result implies that PLC basal activity has some effect on ENaC P o , but that PLC is further activated by G ␤1␥2 expression, and PLC activation plays a major role in G ␤1␥2 inhibition of both ENaC N and P o .
Regulation of ENaC N and P o can be fundamentally different: the former mainly depends on channel trafficking and the later on channel gating. However, activated PLC can conceivably produce changes in both N and P o : P o by reducing plasma membrane PIP 2 levels and N by activating PKC as a consequence of PIP 2 hydrolysis. ENaC P o is influenced by PIP 2 levels (33, 44, 51, 65, 69); however, whether PKC inhibits ENaC surface expression is not completely resolved. Ji et al. (28) reported that several PKC isoforms were involved in SARS virus downregulation of ENaC surface expression. Our result presented in Fig. 5 shows that a PKC inhibitor blocks G ␤1␥2 -mediated ENaC inhibition, and this effect of the inhibitor is mostly due to restoring the channel number in a patch. There are three protein kinase regulatory sites on the C-terminal tails of ␤ and ␥ subunits of ENaC: casein kinase, PKA/ SGK1, and ERK1/2 phosphorylation sites (59); however, a consensus site for PKC on ENaC has never been reported. In fact, attempts to demonstrate direct PKC-mediated ENaC phosphorylation have all been negative (67, 68) . Our results suggests that PKC inhibition of ENaC by a G ␤1␥2 -elicited signal is mostly via ERK1/2. This result is consistent with observations reported by Booth and Stockand (3, 6) in which PKC substantially inhibits ENaC activity in A6 cells, and this inhibition is reversed by ERK1/2 inhibitors of U0126 or PD-98059. It is interesting that ENaC activity of G ␤1␥2 -expressing cells is fully reversed when these cells were exposed to an ERK1/2 inhibitor. In Fig. 5A , NP o of G ␤1␥2 -expressing cells is ϳ40% that of GFP-and RFP-expressing cells, but U0126 treatment brought the NP o of G ␤1␥2 -expressing cells to almost the same value as that of the control cells. Since our patch-clamp, single-channel recording allows us to resolve ENaC activity into components N and P o , we found that like the PKC inhibitor, U0126 significantly restores ENaC N that was suppressed by G ␤1␥2 ; but unlike the PKC inhibitor, it also significantly restored ENaC P o . U0126 stimulates both ENaC N and P o of G ␤1␥2 -expressing cells, implying that the activated ERK1/2 may play dual roles in ENaC regulation. ERK1/2 inhibition of ENaC N and P o was also observed from lung alveolar type II cells when these cells were exposed to strong oxidants (34) . The mechanism by which ERK1/2 reduces ENaC surface expression is by ERK1/2 phosphorylation of ENaC, promoting binding of Nedd4-2 to ENaC and thereby enhancing ENaC internalization and degradation (59) . How- Fig. 7 , but cells were treated with the Src family kinase inhibitor PP2 (10 M) or vehicle (DMSO). The inhibitor had no significant effect on ␤␥ inhibition. ever, the mechanism by which ERK1/2 reduces ENaC P o is unclear. The ERK1/2-mediated effects on ENaC gating may be due to the following: 1) ERK1/2 can directly phosphorylate ENaC ␤, and ␥ subunits at their C-terminal tails, and this phosphorylation may change the channel conformation and therefore reduce its P o ; 2) ENaC P o is enhanced by binding of anionic lipids PIP 2 and PIP 3 (53) , and interaction with these negatively charged lipids may be reduced if ENaC is phosphorylated. Interestingly, in mouse collecting duct principle cells, an increase in amiloride-sensitive short-circuit current was observed when U0126 was applied to control cells, indicating a constitutive inhibition of transepithelial Na ϩ current by ERK1/2 basal activity (19, 62) . However, we did not observe such an increase in our single-channel recording of control cells treated with U0126. A similar result was also reported by Liu et al. (37) , who examined the role ERK1/2 in EGF-and TGF-␣-induced inhibition of ENaC activity in A6 cells. The lack of a stimulatory effect of U0126 on ENaC activity in control A6 cells may be because 1) ERK1/2 basal activity is low in these cells; 2) a transient increase in ENaC activity may have occurred; however, we failed to detect this transient event since our data are the averaged results from cells exposed to U0126 for up to 120 min.
We have also examined the possibility that G ␤1␥2 activates ERK1/2 through PKC-independent signaling pathways. In those PKC-independent pathways, PI3K and Src family kinases are commonly involved in transferring G ␤␥ signal to ERK1/2 (29, 39) . G ␤␥ can activate PI3K␥ by interacting directly with the noncatalytic subunit of P101 and therefore promote the catalytic subunit P110 translocation to the plasma membrane (7). The PI3K inhibitor LY294002 applied to G ␤1␥2 -expressing cells tends to restore the ENaC activity of these cells; however, this stimulation is not statistically significant (Fig. 6) .
In other experiments, we found that the Src family kinase inhibitor PP2 has no effect on ENaC in either G ␤1␥2 or GFPand RFP-expressing cells. Src family kinases contribute at various steps to G ␤␥ trans-activation of mitogenic signaling pathways (56) , but based on our results, we suggest that PKC-independent pathways are not significantly involved in G ␤1␥2 activation of ERK1/2.
In conclusion, G ␤␥ inhibition of ENaC activity in A6 cells is G ␤ isoform specific, and in this cellular context PLC and activation of PKC and ERK1/2 play a major role in transducing G ␤1␥2 signals to ENaC. 
